Each ml contains 10,000 Units of Crisantaspase
It is used for Acute lymphoblastic leukemia Treatment (in combination with other chemotherapy) of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase
- Presentation: Injection
- Strength: 10,000 Units
- Pack Size: 5 Vials.
- Pack Insert: Yes
- Marketing Authorization Holder: Porton Biopharma Limited.
- Manufacturing License: PL 44403/0002